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The RNA-dependent protein kinase (PKR) is implicated in the antiviral and antiproliferative actions of interferon. Mutant
forms of human PKR display a transdominant behavior when expressed in transfected cells. The potential for the human
PKR protein to physically interact with the mouse PKR homolog has therefore been examined. The yeast two-hybrid system
was used to probe the association between mouse and human PKR proteins as measured by activation of two Gal4-
responsive reporter genes, HIS3 and lacZ. Expression of full-length wild-type mouse PKR(1-515)WT as a Gal4 fusion protein
did not exhibit the growth suppression phenotype in yeast characteristic of wild-type human PKR(1-551)WT. Coexpression
of mouse PKR(1-515)WT as a Gal4 DNA-binding domain fusion with either the catalytic-deficient human PKR(1-551) K296R
mutant, the RNA-binding-deficient human PKR(1-551)K64E/K296R double mutant, or wild-type mouse PKR(1-515)WT as full-
length PKR-Gal4 activation domain fusions resulted in activation of the HIS3 and lacZ reporters. The N-terminal RNA-binding
region of human PKR, both WT and the K64E RNA-binding-deficient mutant, also interacted with mouse PKR(1-515)WT
sufficiently to activate the reporters but the human catalytic region did not. Mouse and human full-length PKR proteins
expressed as glutathione S-transferase (GST) fusions in Escherichia coli were purified on Sepharose beads. Using GST-
PKR fusion chromatography, direct physical interaction between the mouse and human PKR homologs was established.
Intraspecies PKR interactions were more efficient than interspecies PKR interactions, and interactions between RNA-binding-
sufficient PKR proteins were more efficient than those involving an RNA-binding mutant as measured by binding to GST-
PKR protein Sepharose beads. The N-terminal region of human PKR within amino acids 1–184 was sufficient for binding
mouse PKR. Purified mouse full-length PKR(1-515)WT GST fusion protein retained kinase activity on Sepharose beads, but
the activity was not impaired by association with either the full-length or the N-terminal region of human PKR. q 1997
Academic Press
INTRODUCTION virus, histones, and an unidentified 90-kDa cellular pro-
tein. Both cDNA clones (Meurs et al., 1990; Icely et al.,
Interferons are a class of regulatory cytokines that dis-
1991; Thomis et al., 1992; Baier et al., 1993) and genomic
play a wide range of biological activities. Interferons (IFN)
clones (Tanaka and Samuel, 1994; Kuhen and Samuel,
can profoundly affect a variety of functions in animal cells 1997; Kuhen et al., 1996) of the mouse and human PKR
and whole animals, including virus multiplication, cell homologs have been isolated and extensively character-
growth and differentiation, and the immune response ized in structural and functional terms (Samuel, 1993;
(David, 1995; Jaramillo et al., 1995; Landolfo et al., 1995; Clemens, 1996). As deduced from nucleotide sequence
Pestka et al., 1987; Vilcek and Sen, 1996). Among the data, the human PKR is a 551-amino-acid protein,
enzymes implicated in the antiviral and cell growth regu- whereas the mouse PKR is a somewhat smaller protein
latory responses of IFN is the IFN-inducible and RNA- of 515 amino acids. Among the domains responsible for
dependent protein kinase, PKR (Samuel, 1993; Clemens, the regulation and catalysis of PKR are the two copies
1996; Samuel et al., 1997). of the RNA-binding subdomain R-motif located in the
PKR is a serine/threonine protein kinase that catalyzes amino-terminal half of PKR and the multiple conserved
two types of phosphorylation reactions: PKR catalyzes catalytic subdomains characteristic of serine/threonine
the autophosphorylation of itself which can be activated kinases which are located in the carboxyl-terminal half
by RNA; and PKR catalyzes the phosphorylation of a of the PKR protein (McCormack et al., 1992; Samuel,
growing number of substrates including protein synthe- 1993; Clemens, 1996). The expression and function of
sis initiation factor eIF-2, the transcription factor inhibitor PKR is regulated at many levels: transcriptional induction
I-kB, Tat protein encoded by human immunodeficiency of the PKR gene by IFN (Meurs et al., 1990; Tanaka and
Samuel, 1994; Kuhen and Samuel, 1997); translational
autoregulation of PKR protein synthesis (Thomis and1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (805) 893-4724. Samuel, 1992; Barber et al., 1993); posttranslational acti-
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vation by autophosphorylation (Samuel, 1979: Thomis MATERIALS AND METHODS
and Samuel, 1993; Taylor et al.,1996); and posttransla-
Materialstional protein–protein interactions (Lee et al., 1992; Park
et al., 1994; Gale et al., 1996; Ortega et al., 1996; Benkir-
Wild-type and mutant constructions of the human PKRane et al., 1997). Furthermore, a number of viral and
cDNA (HuPKR) were previously described as follows: wild-cellular protein and RNA effectors of PKR kinase function
type WT(1-551) and the catalytic-negative subdomain II mu-have been identified (Samuel, 1993; Mathews, 1993;
tant K296R(1-551) in pBluescript (Thomis and Samuel,Katze, 1995; Jacobs and Langland, 1996).
1992); the RNA-binding negative mutant K64E(1-551) andMultiple lines of evidence suggest that PKR plays an
the double mutant K64E/K296R(1-551) in pBluescriptimportant role in the control of cell growth (Lengyel, 1993)
(McCormack et al., 1994); and plasmid constructions thatin addition to the antiviral actions of IFN (Samuel, 1991).
encoded HuPKR protein fused at the N-terminus to eitherCatalytically inactive forms of the human PKR protein can
the DNA-binding domain (GAL4bdPKR(1-551)K296R) or thereverse the growth suppression phenotype mediated by
transcription activation domain (GAL4adPKR(1-551)K296R;wild-type human PKR in yeast (Chong et al., 1992; Ro-
GAL4adPKR(1-551)K64E/K296R) (Ortega et al., 1996). Wild-mano et al., 1995), and when overexpressed in mouse
type mouse PKR cDNA (MsPKR), WT(1-515), was as pre-
NIH3T3 cells causes morphologic transformation of the
viously described (Tanaka and Samuel, 1994). The N-termi-
3T3 cells in culture which become tumorigenic when
nal histidine-tagged WT HuPKR constructs p184(WT) and
injected into nude mice (Koromilas et al., 1992; Meurs et
p220(WT) in the expression vector pET14b, corresponding
al., 1993). Malignant transformation of mouse 3T3 cells to amino acids 1–184 and 1–220, respectively (Bevilacqua
mediated by overexpression of inactive human PKR pro- and Cech, 1996), were derived from WT(1-551) (Thomis
teins is observed when the human PKR homolog is mu- and Samuel, 1992) and were generously provided by Dr.
tated in either the catalytic domain or the RNA-binding T. Cech (University of Colorado, Boulder). The K64E mutant
domain (Koromilas et al., 1992; Meurs et al., 1993; Barber forms of p184 and p220, p184(K64E), and p220(K64E), re-
et al., 1995b). Thus, PKR not only plays a critical role in spectively, were constructed by interchanging a 300-bp
the antiviral actions of IFN (Samuel, 1991; Vilcek and NdeI–StuI fragment containing the K64E mutation from
Sen, 1996) but also is important in the regulation of cell pBluescript HuPKR(K64E) (McCormack et al., 1994) with
growth and differentiation (Petryshyn et al., 1988; Koromi- the corresponding wild-type fragment in the pET14b-based
las et al., 1992; Meurs et al., 1993; Lengyel, 1993; Lee et constructions. The yeast Gal4 DNA-binding domain (BD;
al., 1997). pAS1-CYH2) and Gal4 activation domain (AD; pACTII) plas-
The mechanism by which PKR is activated by dsRNA mid vectors were generously provided by Dr. S. J. Elledge
and how this leads to autophosphorylation and subse- (Baylor College of Medicine, Houston, TX) (Durfee et al.,
quent modulation of cell growth is not yet fully under- 1993). The GAL4-MsPKR fusion GAL4bdPKR(1-515)WT and
stood. Evidence that PKR interacts with itself in the con- the GAL4-HuPKR fusions GAL4adPKR(1-184)WT, GA-
text of an enzyme–substrate interaction has been dem- L4adPKR(1-184)K64E, GAL4adPKR(1-220)WT, and GA-
onstrated in vitro (Kostura and Mathews, 1989; Thomis L4adPKR(1-220)K64E were constructed following standard
and Samuel, 1993), and a number of studies have de- procedures for DNA manipulations (Sambrook et al., 1989).
scribed PKR–PKR physical interactions and the forma- Full-length wild-type MsPKR and both full-length mu-
tion of intraspecies homodimers both in vivo and in vitro tants of HuPKR, K296R, and K64E/K296R were expressed
(Langland and Jacobs, 1992; Cosentino et al., 1995; Patel in Escherichia coli BL21(DE3)pLysE as fusion proteins
et al., 1995; Ortega et al., 1996; Wu and Kaufman, 1996). with glutathione S-transferase (GST) using the expres-
A controversial point is the dsRNA binding requirement sion vector pGEX-KG (Guan and Dixon, 1991; Patterson
for dimerization and the dimerization requirement for and Samuel, 1995). Rabbit polyclonal antiserum prepared
dsRNA-dependent PKR activation. against recombinant TrpE-HuPKR fusion protein was as
As an extension of our studies of the structure and previously described (Thomis et al., 1992); polyclonal an-
function of the PKR kinase, we have used both genetic tiserum prepared against recombinant GST-MsPKR fu-
and biochemical approaches to examine the physical sion protein as described for GST-ADAR (Patterson and
association between wild-type mouse PKR and inactive Samuel, 1995) was generously provided by Dr. John Pat-
mutant forms of the human PKR homolog. Our results terson of our laboratory. Natural PKR(WT) kinase was
establish that interspecies association between mouse purified from the ribosomal salt-wash fraction prepared
and human PKR homologs occurs both in vitro and in from IFN-treated human amnion U cells as previously
vivo, that the association is mediated through the N- described (Berry et al., 1985), except that the procedure
terminal region of the proteins, and that the autophos- was modified to include a MonoQ ion-exchange fast pro-
phorylation activity of mouse PKR is not impaired by the tein liquid chromatography (FPLC) step (Thomis and
Samuel, 1993).association with human PKR.
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Expression of PKR fusion proteins bound proteins were eluted as described (Guan and Dixon,
1991) prior to analysis by SDS–PAGE.
All GST- and His-tag PKR fusion proteins were ex- For binding assays between mouse and human PKR
pressed in E. coli BL21(DE3)pLysE. Fresh transformants proteins, either human or mouse GST-PKR fusion protein
were used to inoculate LB broth containing 100 mg/ml bound to glutathione–Sepharose 4B beads or beads
ampicillin. Cultures of uninduced cells were grown to an containing only GST were incubated with cell-free cyto-
OD600 of 0.4 to 0.8, at which time isopropyl b-D-thiogalac- plasmic extract (1 ml) prepared from either IFN-treated
topyranoside (IPTG) was added to a final concentration human U-cells or mouse L-cells as indicated. Incubation
of 0.1 mM and incubation continued for an additional 4 was done at 47 for 1 h with gentle rocking. The unbound
h. Induction was performed at 347 in order to increase material from each binding mixture was collected and
the amount of soluble fusion protein. Cultures were har- the GST-PKR affinity column bead was then washed step-
vested by centrifugation and washed, and the bacterial wise as follows: 31 with 5 ml LB; 31 with 100 ml buffer
pellets were resuspended in lysis buffer [LB: 0.65% Noni- A (20 mM HEPES, 200 mM NaCl, 1 mM PMSF, 10 mM
det P40, 20 mM HEPES, 150 mM NaCl, 5 mM EDTA, 1 benzamidine, 0.5 u a-macroglobulin); 31 with 100 ml
mM PMSF, 10 mM benzimidine, and 1 U a-macroglobulin buffer B (buffer A modified to contain 750 mM NaCl); 3
(Boehringer)] and sonicated before centrifugation at 47 to 51 with 100 ml EB (buffer A containing 10 mM glutathi-
for 20 min at 12,000 rpm. The supernatant fraction was one and 20 mM KCl in place of the NaCl) buffer (Guan
collected and analyzed for protein content by SDS–PAGE and Dixon, 1991). Where noted, equimolar amounts of
followed by staining with Coomassie brilliant blue and/ recombinant HuPKR truncation mutants (p184 or p220)
or by Western immunoblot analysis. expressed in E. coli were incubated with GST-MsPKR
immobilized on glutathione–Sepharose matrix. The affin-
Western immunoblot analysis ity matrix and extracts were incubated for 30 min at 47
with gentle rocking before separation of the matrix bead-Western immunoblots were prepared as previously de-
bound proteins and the supernatant fraction containingscribed, using antiserum prepared against either recom-
unbound proteins by centrifugation. The Sepharose beadbinant human PKR or recombinant mouse PKR expressed
pellet with the bound proteins was washed extensivelyin E. coli (Towbin et al., 1979; Thomis et al., 1992).
(41 with 1 ml LB); the final washed bead pellet was
suspended in Laemmli gel loading buffer, boiled, and
Cell maintenance and interferon treatment analyzed by SDS–PAGE and Western immunoblotting.
Human amnion U cells and mouse fibroblast L cells PKR interaction assays in the yeast two-hybrid
were maintained in Dulbecco’s modification of Eagle’s me- system
dium (DMEM) supplemented with fetal bovine serum Mouse–human interspecies heteromeric PKR–PKR
(HyClone) at 5% (v/v), 100 units/ml of penicillin and 100 protein interactions in vivo in yeast were measured by
mg/ml of streptomycin. Interferon treatment was performed activation of HIS3 and lacZ reporter constructs as de-
with 1000 IU/ml of IFN-a for 24 h. Cell-free cytoplasmic tected by growth and color assays, respectively (Durfee
extract fractions (S10) were prepared as previously de- et al., 1993). The procedures have been recently de-
scribed (Thomis et al., 1992; McMillan et al., 1995). scribed in detail (Ortega et al., 1996). Briefly, the cDNA
encoding full-length wild-type mouse PKR was sub-
PKR purification and protein binding assays cloned into both the Gal4 DNA-binding (pAS1-CYH2) and
activation (pACTII) domain vectors as a BamHI–XhoIPKR purification and protein-binding assays were car-
fragment. The Gal4 fusion constructions encoding mu-ried out using GST-PKR fusion polypeptide affinity chroma-
tant human PKR proteins, either GAL4bd or GAL4ad fu-tography essentially as previously described (McMillan et
sions of PKR(1-551)K296R and PKR(1-551)K64E/K296R,al., 1995). Briefly, glutathione–Sepharose 4B beads
were as described (Ortega et al., 1996). The N-terminal(Sigma) were washed extensively and suspended in LB
region of the human PKR protein, either as the N-terminalcontaining 2% skim milk. A supernatant solution of E. coli
184 or as the 220 amino acids, was expressed both inBL21(DE3)pLysE extract containing GST-PKR fusion pro-
the wild-type and the K64E mutant forms. The N-terminal
tein, either recombinant wild-type or mutant human or
PKR fragments were subcloned as blunted NdeI–HinfI
mouse GST-PKR as indicated, was then incubated with
or NdeI–DraI fragments from parent pET14b expression
the washed glutathione–Sepharose beads for 1 h at 47
vector constructs into the SmaI site of the GAL4 pACTII
with gentle shaking and applied to a Bio-Rad column (10
activation domain vector.
ml), and the bead matrix material was extensively washed
In vitro PKR autophosphorylaton assay(5 1 5 ml LB). Sepharose bound GST-fusion proteins were
analyzed directly by treating the beads with SDS–PAGE [g-32P]ATP-mediated autophosphorylation of PKR was
measured essentially as previously described (Samuelsample loading buffer and boiling, or alternatively, the
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et al., 1986; George et al., 1996). Briefly, wild-type mouse Mouse and human PKR protein homologs interact
with each other via the N-terminal regions asrecombinant PKR kinase expressed in E. coli as a GST-
PKR fusion protein was purified as a GST-PKR/glutathi- measured by the yeast two-hybrid system
one–Sepharose complex. Autophosphorylation of immo-
The yeast two-hybrid system (Fields and Song, 1989)bilized GST-PKR mouse kinase was examined either
was used to initially examine the ability of mouse PKRalone, or in association with human mutant PKR proteins,
to form heteromeric complexes with human PKR. Expres-either the full-length K296R protein or the WT or K64E
sion plasmids were constructed encoding PKR cDNAsmutant version of the N-terminal 220 aa region. [g-
fused at their N-termini to either the DNA-binding domain32P]ATP-mediated autophosphorylation reactions were
(BD) or the transcription activation domain (AD) of thecarried out either in the presence or in the absence of
yeast Gal4 protein. The various PKR proteins examineddsRNA (poly rI:rC). 32P-labeled products were analyzed
in this way included the full-length 515-amino-acid wild-by SDS–polyacrylamide gel electrophoresis and autora-
type mouse PKR protein (Tanaka and Samuel, 1994); thediography.
full-length 551-amino-acid single (K296R) and double
(K64E/K296R) substitution mutant human PKR proteins;
Quantitative analysis and the truncated N-terminal RNA binding and catalytic
domains of human PKR (Table 1). Plasmids encoding theQuantitation of 125I- or 32P-labeled products was per-
various hybrid PKR-Gal4 proteins were coexpressed informed by directly imaging nitrocellulose immunoblot fil-
the yeast Y190 host possessing two easily detectableters and dried polyacrylamide gels using a Bio-Rad
reporter genes, histidine (HIS3) and b-galactosidaseModel GS-525 Molecular Imager or by scanning autora-
(lacZ), under the control of Gal4. Leucine and tryptophandiograms using an LKB Ultroscan XL laser densitometer.
auxotrophic markers were used to select for yeast that
had been transformed with the activation or DNA-binding
domain plasmids, followed by use of the dual detectionRESULTS
system to screen for yeast that had been transformed
with a pair of plasmids encoding PKR–PKR interactingPKR is an interferon-inducible protein kinase that plays
proteins. HIS3 gene expression was detected by growtha central role in the antiviral actions of interferon and is
on plates lacking histidine, and lacZ gene expressionimplicated in the control of cell growth (Samuel, 1991; Len-
was detected by the filter lift assay.gyel, 1993; Clemens, 1996). It was observed that catalyti-
The results of analysis of pairwise combinations ofcally inactive mutants of human PKR such as K296R,
Gal4 BD and Gal4 AD protein fusions with PKR are sum-K296P, D6, and K64E/K296R stimulate protein synthesis
marized in Table 1. In the first series of experiments, thein transiently transfected cells and mediate transformation
interactions of full-length PKR Gal4 protein fusions werein cell culture and tumor formation in animal models (Koro-
examined. Cells expressing the BD fusion of mouse PKRmilas et al., 1992; Meurs et al., 1993; Barber et al., 1995;
with AD fusion of human PKR, either as the catalyticallyHenry et al., 1994; Ortega et al., 1996; Wu and Kaufman,
inactive single mutant K296R or as the double mutant1996). The mechanism by which exogenously introduced
K64E/K296R that also lacks RNA-binding activity, grewmutant forms of PKR act as transdominant negative inhibi-
in the absence of histidine and synthesized b-galactosi-tors of endogenous PKR function is not well resolved. One
dase. These results indicate that physical interaction oc-possible explanation for the dominant negative property of
curred between the mouse and human PKR homologs.mutant PKR measured by cell growth and tumor formation
By contrast, cells expressing only one of the Gal4 do-assays (Koromilas et al., 1992; Meurs et al., 1993; Barber
mains as a full-length PKR fusion and the other Gal4et al., 1995a) involves the formation of heteromeric com-
domain alone without fused PKR, for example, either BDplexes between the exogenously introduced mutant hu-
alone and the AD fusion of human PKR(K296R) or BDman PKR protein and the endogenous wild-type mouse
fusion of mouse PKR(WT) and the AD alone, did not growPKR protein that subsequently alters PKR function. The
on medium lacking histidine and did not express b-galac-formation of PKR homodimers of either mouse PKR (Lang-
tosidase. Because of the growth suppression activity ofland and Jacobs, 1992) or human PKR (Patel et al., 1995;
human PKR(WT) expressed in yeast (Chong et al., 1992),Cosentino et al., 1995; Ortega et al., 1996; Wu and Kaufman,
the human PKR(K296R) mutant lacking enzyme activity1996; Carpick et al., 1997) is well established. However,
was used as the reference human construction (Ortegathe formation of interspecies PKR heterodimers between
et al., 1996). Unexpectedly, the mouse PKR(WT) ex-mouse and human PKR proteins is not yet firmly estab-
pressed in yeast did not display a comparable growthlished. We have used genetic and biochemical approaches
suppressive characteristic and thus could be used asto examine the ability of mouse and human PKR proteins
the reference mouse construction.to form interspecies heterodimers and the effect of dimer-
ization on PKR activity. In the second series of experiments, the interactions
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TABLE 1
Interaction between Mouse and Human PKR Proteins Detected by the Two-Hybrid System
Note. Y-190 cells were cotransformed with expression vectors encoding various GAL 4 DNA-binding domain (BD) and GAL 4
transcription activation domain (AD) fusion proteins as indicated. Wild-type and mutant forms of the RNA-dependent protein kinase
(PKR) cDNA, either human (hatched bars) or mouse (filled bars), were as previously described (Thomis and Samuel, 1992; McCormack
et al., 1994; Tanaka and Samuel, 1992). For the growth experiments, aliquots of the same transformation mixture were plated on either
synthetic dextrose plates lacking tryptophan and leucine or plates lacking tryptophan, leucine, and histidine but containing 25 mM 3-
aminotriazole. Plus (/) signs indicate growth of the transformed yeast colonies on the respective plates. b-Galactosidase (X-gal)
activity was determined by the colony nitrocellulose filter lift method. Blue colony color indicates transcriptional activation of the lacZ
reporter under the control of GAL4-binding site, which requires PKR–PKR interaction to bring the GAL4 activation and DNA-binding
domains of the GAL4-PKR fusion proteins together. White colony color indicates a lack of interaction between GAL4-PKR fusion proteins
sufficient to activate transcription.
of truncated human PKR protein fusions were examined the N-terminal region of human PKR grew in the absence
of histidine and synthesized b-galactosidase whenwith full-length mouse PKR(WT) fusions. Cells expressing
the BD fusion of mouse PKR with AD fusion of truncated tested with the full-length mouse PKR. By contrast, cells
expressing the C-terminal catalytic region of humanhuman PKR, either the N-terminal 184 or the 220 amino
acids that included the RNA-binding domain, grew in the PKR(281-551) and full-length mouse PKR(WT) did not
grow in the absence of histidine and did not synthesizeabsence of histidine and synthesized b-galactosidase.
Furthermore, both the WT and the K64E mutant forms of b-galactosidase. These results suggest that the mouse
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FIG. 1. Expression and characterization of glutathione S-transferase (GST) PKR fusion proteins. (A) Purification of GST-PKR fusion proteins. GST
alone and GST-PKR fusion proteins expressed in E. coli were bound to glutathione Sepharose 4B beads. After extensive washing of the beads with
the binding buffer, the GST-PKR fusion proteins were analyzed by SDS–PAGE and detected by staining with Coomassie brilliant blue. Lane 1, GST-
MsPKR(WT); lane 2, GST-HuPKR(K64E/K296R); lane 3, GST-HuPKR(K296R); lane 4, GST alone; lane 5, molecular weight standard. The bottom bands
in lanes 1, 2, and 3 likely are degradation products of the GST-PKR fusion proteins. (B) Autophosphorylation activity of GST-MsPKR(WT). In vitro
autophosphorylation assays were performed using comparable amounts of Sepharose-bound GST-MsPKR(WT), either in the absence (lane 3) or in
the presence (lane 4) of 0.1 mg/ml dsRNA. 32P-labeled phosphoproteins were analyzed by SDS–PAGE and autoradiography.
and human homologs of PKR form heterodimers in vivo 1). This allowed for the subsequent utilization of the
in yeast in an RNA-independent manner that involves MsPKR(WT) protein in the PKR–PKR interaction analysis
the N-terminal region of human PKR in the interspecies by GST-fusion chromatography. Autophosphorylation ac-
protein–protein interactions. tivity of purified GST-MsPKR immobilized to the glutathi-
one–Sepharose matrix was evaluated in the presence
Mouse and human PKR protein homologs interact or absence of dsRNA activator using labeled [g-32P]ATP.
with each other as measured by GST-fusion affinity The GST-MsPKR(WT) protein retained autophosphoryla-
chromatography tion activity (Fig. 1B, lanes 3 and 4). In agreement with
prior observations (Kumar et al., 1994), the activity of theTo further investigate the PKR protein–protein interac-
GST-PKR(WT) protein did not display a dsRNA depen-tions, glutathione–Sepharose affinity chromatography
dence (Fig. 1B, lanes 3–4), in contrast to the well-estab-was used. GST-PKR fusion proteins expressed in E. coli
lished dsRNA-dependent activity observed for PKR ex-were bound to Sepharose beads, and protein-binding
pressed in IFN-treated mammalian cells (Fig. 1B, lanesassays were performed to assess the interaction be-
1 and 2).tween recombinant GST-PKR and endogenous mouse
For analysis of protein–protein interactions by GST-or human PKR expressed in IFN-treated L- or U-cells,
fusion chromatography, the binding of PKR to a GST-PKRrespectively. We were not able to express the full-length
column was compared to the binding obtained with awild-type HuPKR GST-fusion in E. coli (data not shown),
similar column made from GST alone. The protein–Seph-as was previously found for the HuPKR TrpE-fusion in E.
arose bead matrices were reacted separately with L- orcoli (Thomis et al., 1992). However, the full-length wild-
U-cell-free cytoplasmic extracts and eluted in a stepwisetype GST-MsPKR fusion surprisingly was efficiently ex-
pressed and could be purified from E. coli (Fig. 1A, lane manner with buffers containing either 0.2 or 0.75 M salt or
AID VY 8824 / 6a53$$$301 10-28-97 19:43:36 viras AP: VY
416 RENDE-FOURNIER ET AL.
FIG. 2. Retention of natural PKR from interferon-treated cells on a GST-PKR Sepharose 4B affinity column matrix. GST alone, GST-MsPKR(WT),
GST-HuPKR(K296R), or GST-HuPKR(K64E/K296R) fusion proteins were bound to glutathione–Sepharose 4B beads. The protein beads were then
reacted with cell-free extracts prepared from IFN-treated human amnion U- or mouse fibroblast L-cells and eluted as follows: unbound (lane 1);
eluate obtained with buffer containing 0.2 M NaCl (lanes 2–4), 0.75 M NaCl (lanes 5–7) , and then 10 mM glutathione (lanes 8–12). Lane 13 shows
the starting material cell-free extract from either IFN-treated U- or L-cells as indicated. Eluates were analyzed by SDS–PAGE and Western immunoblot
analysis. For detection of mouse PKR, blots were probed with rabbit antiserum raised against recombinant mouse PKR GST-fusion; for detection
of human PKR, blots were probed with rabbit antiserum raised against recombinant human PKR TrpE-fusion. (A) GST-MsPKR(WT) affinity column
matrix, with IFN-treated L-cell extracts; (B) GST affinity column matrix lacking fused PKR, with IFN-treated L-cell extracts; (C) GST-MsPKR(WT) affinity
column matrix, with IFN-treated U-cell extracts; (D) GST affinity column matrix lacking fused PKR, with IFN-treated U-cell extracts; (E) GST-
HuPKR(K296R) affinity column matrix, with IFN-treated U-cell extracts; (F) GST-HuPKR(K64E/K296R) affinity column matrix, with IFN-treated U-cell
extracts. Lower molecular weight products in E and F most likely represent degradation products of the HuPKR protein rather than altered
phosphorylation forms of the protein because of the band positions. The region of the gels corresponding to the native mouse and human PKR
proteins are shown.
glutathione, and the fractions were analyzed by Western the U cell extract with cobra venom RNase V1 reduced
the binding of the endogenous PKR(WT) by the GST-immunoblotting. GST-MsPKR(WT) beads were first tested
for interaction with the endogenous MsPKR from IFN- MsPKR column about three- to four-fold, suggesting that
the interaction was probably dependent in part upon antreated L-cells. The GST-MsPKR(WT) column bound
mouse PKR from IFN-treated L-cells (Fig. 2A). The GST- RNA bridge (data not shown).
Because it was not possible to express the wild-typeMsPKR:MsPKR interaction was selective, because high
salt or glutathione was required to elute the bound human PKR in yeast as a Gal4-PKR fusion, wild-type hu-
man PKR could not be analyzed by the two-hybrid tech-MsPKR from the GST-MsPKR(WT) fusion column (Fig.
2A) and because no binding was observed when L-cell nique for protein–protein interaction (Chong et al., 1992;
Ortega et al., 1996). Therefore, we attempted to extendextracts were passed through an affinity column made
from GST alone (Fig. 2B). A similar interaction was ob- the PKR–PKR interaction results previously obtained with
mutant versions of human PKR in the two-hybrid assayserved when the GST-MsPKR column was examined with
PKR from IFN-treated U-cell extracts: the wild-type en- (Table 1; Ortega et al., 1996) to include wild-type human
PKR in the GST-fusion chromatography assay (Fig. 2).dogenous PKR in human U-cells was retained by the
GST-MsPKR column (Fig. 2C), whereas it was not re- GST-fusion columns made with mutant human PKR pro-
teins defective in catalytic activity and or RNA-bindingtained by column of GST alone (Fig. 2D). Pretreatment of
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TABLE 2 Sepharose beads was allowed to incubate with a limiting
amount of truncated PKR protein. The subsaturating con-Binding of Human PKR Protein to Sepharose Matrices Containing
dition was established by testing serial dilutions ofRecombinant GST-PKR Fusion Proteins
p220(WT) HuPKR against a constant amount of GST-
HuPKR MsPKR affinity matrix (data not shown). Comparable mo-
Affinity matrix (% bound) lar amounts of p220(K64E), p184(WT), and p184(K64E)
determined by immunoblotting were then examined forGST-MsPKR 34
binding to GST-MsPKR beads. Both the wild-type and theGST-HuPKR(K296R) 56
GST-HuPKR(K64E/K296R) 13 K64E mutant forms of p184 and p220 were retained by
GST alone Nil the GST-MsPKR affinity column (Fig. 3, top, lanes 2– 5).
Neither the p184(WT) nor the p220(WT) protein was
Note. The two full-length human PKR mutant proteins. K296R and
bound in a detectable amount by a similar column ofK64E/K296R, expressed in Escherichia coli were used to prepare Seph-
Sepharose beads containing GST alone (Fig. 3, top, lanesarose affinity columns. Soluble natural PKR protein from cytoplasmic
extracts of IFN-treated human U-cells (HuPKR) was examined for its 6 and 7). Analysis of aliquots of the bound and unbound
ability to bind a Sepharose affinity column containing immobilized GST- column fractions revealed comparable amounts of GST-
PKR fusion proteins or GST alone. Affinity columns were washed exten- MsPKR fusion, which, as expected, was present only in
sively as described under Materials and Methods. Proteins retained
the bound fractions (Fig. 3, bottom, lanes 1–5).on the column after the final wash were considered bound. Quantitation
Quantitation of the binding data shown in Fig. 3 re-was by Western immunoblot analysis and is expressed as the percent-
age (%) of natural PKR protein bound to the column. Nil, none detected. vealed that the p184 and p220 wild-type versions of
HuPKR bound to the GST-MsPKR columns with compara-
ble efficiency (Table 3). Neither p184 nor p220 bound
activity, either the single mutant GST-HuPKR(K296R) or significantly to Sepharose beads containing GST alone.
the double mutant GST-HuPKR(K64E/K296R), both bound The K64E mutation reduced the binding about threefold,
PKR from IFN-treated U cells (Figs. 2E and 2F). both for p184 and for p220. These results obtained with
The quantitation of the binding of natural wild-type hu- the N-terminal region of HuPKR (Table 3), together with
man PKR to the various GST-PKR Sepharose bead matri- those obtained with full-length HuPKR (Table 2), suggest
ces is shown in Table 2. The most efficient PKR–PKR that the interspecies binding to MsPKR(WT) of the trun-
interaction observed was the intraspecies interaction be- cated and full-length versions of HuPKR(WT) occurs with
tween natural HuPKR and the GST-HuPKR(K296R) fusion comparable efficiency and that retention of RNA-binding
(56% bound). The intraspecies interaction between natural activity of HuPKR enhances but is not required for the
HuPKR and the RNA-binding deficient GST-HuPKR(K64E/ interspecies PKR–PKR interactions.
K296R) double mutant was less efficient (13% bound), as
was the interspecies interaction between HuPKR and GST-
Heterodimer formation between human and mouseMsPKR (34% bound). No detectable binding was observed
PKR homologs does not impair autophosphorylationbetween the HuPKR and GST alone. These results suggest
activity of mouse PKRthat while dsRNA-binding activity is not required for
PKR:PKR interactions, either dsRNA-binding activity in- The results obtained by both yeast two-hybrid analysis
creases the stability of the protein interaction or alterna- (Table 1) and GST-PKR fusion chromatography (Tables
tively the K64E mutation alters the conformation of PKR in 2 and 3) suggest that the mouse and human homologs
a manner that adversely affects the stability of the subse- of PKR form heterodimers both in vivo and in vitro that
quent protein–protein interaction. involve the N-terminal region of human PKR. As an ap-
proach to assess the effect of the heterodimer formation
RNA binding requirement for interspecies protein
on the autophosphorylation activity of PKR, the autophos-
interaction between MsPKR and the N-terminal region
phorylation of recombinant mouse protein bound to
of HuPKR
Sepharose beads was examined in the absence and in
the presence of added human PKR (Fig. 4). Purified matrixTo further investigate the dependence of protein–pro-
tein interactions between MsPKR and HuPKR on RNA- bound recombinant mouse GST-PKR(WT) fusion protein
expressed in E. coli displayed autophosphorylation activ-binding activity, either the N-terminal 184 or the 220
amino acid region of human PKR that includes the RNA- ity (Fig. 4, lane 2); the autophosphorylation of GST-
PKR(WT) was independent of double-stranded RNA (Fig.binding domain were examined both as WT and K64E
mutant forms for their ability to bind to Sepharose beads 1B), in agreement with the earlier results of Kumar et al.
(1994). Neither an excess of the wild-type or the K64Econtaining wild-type GST-MsPKR. The p184 and p220
truncations of HuPKR used in the binding analysis were mutant form of the human PKR p220 N-terminal domain
nor the full-length human GST-PKR(K296R) mutant pro-expressed in E. coli as histidine-tagged proteins. For
the binding analyses, an excess amount of GST-MsPKR tein affected the autophosphorylation of the full-length
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FIG. 3. Characterization of the N-terminal region of recombinant HuPKR. Retention of the N-terminal region of recombinant HuPKR on a GST-
MsPKR Sepharose 4B affinity column matrix. Comparable molar amounts of p184 and p220 human PKR proteins, either wild-type or K64E mutant,
were incubated with affinity column matrix containing either GST-MsPKR or GST alone as indicated. After washing with buffer, bound and unbound
fractions were analyzed by SDS –PAGE and Western immunoblot analysis. The regions of the blot corresponding to the N-terminal truncation (top)
and the column matrix GST-MsPKR fusion (bottom) are shown.
mouse GST-PKR(WT) fusion protein (Fig. 4, lanes 3–5). PKR homolog that involves the N-terminal region of PKR.
This interspecies PKR interaction, while not RNA depen-The full-length human GST-PKR(K296R) mutant fusion
lacked detectable activity when examined alone, in the dent, is more efficient with wild-type than with RNA-bind-
ing mutant PKR proteins and occurs in a manner thatabsence of mouse GST-PKR(WT) (Fig. 4, lane 6). These
results suggest that heterodimer formation between hu- does not inactivate the autophosphorylation activity of
mouse PKR kinase.man and mouse PKR homologs does not impair the auto-
phosphorylation activity of mouse PKR. It is well established in the literature (Langland and
Jacobs, 1992; Cosentino et al., 1995, Patel et al., 1995;
Ortega et al., 1996, Wu and Kaufman, 1996) that PKR–DISCUSSION
PKR interactions can occur to form intraspecies homodi-
PKR is an RNA-activated serine/threonine protein ki-
mers, either MsPKR:MsPKR or HuPKR:HuPKR. Our re-
nase that plays a central role in the antiviral actions of
sults reported herein establish that interspecies PKR het-
interferon (Samuel, 1991) and also is implicated in the
erodimers can also form between the mouse and the
control of cell proliferation (Lengyel, 1993). PKR function
human homologs. The highest values observed for PKR–
is regulated at many levels, including transcription, trans-
lation, and posttranslation by phosphorylation and by
TABLE 3protein–protein interactions (Samuel, 1993; Clemens,
1996). One of our interests is to understand the regulatory Binding of Wild-Type and Mutant Human PKR N-Terminal Domain
to Mouse GST-PKR Fusion Proteininteractions of PKR with itself and other cellular proteins.
PKR is constitutively expressed in small amounts in
GST-MsPKR Gstmany kinds of animal cells (Pestka et al., 1987). Overex-
Hu-PKR (% bound) (% bound)
pression of mutants of human PKR lacking catalytic activ-
ity leads to enhanced protein synthesis in cultured cells p184(WT) 39 1
p184(K64E) 12 ND(Ortega et al., 1996; Wu and Kaufman, 1996) and to induc-
p220(WT) 35 4tion of malignant transformation in mice injected with 3T3
p220(K64E) 14 NDmouse fibroblasts overexpressing human PKR mutants
(Koromilas et al., 1992; Meurs et al., 1993; Barber et al., Note. Wild-type (WT) and K64E mutant forms of the N-terminal 184
1995b). One explanation for the transdominant behavior (p184) or 220 (p220) amino acids of human PKR (HuPKR) expressed in
Escherichia coli were examined for their ability to bind to full-lengthof PKR is the formation of heterodimers between the
WT mouse PKR expressed as a GST-PKR fusion protein. Human PKRexogenously introduced mutant human PKR protein and
binding to Sepharose matrix, either GST-MsPKR or GST alone, wasthe endogenous wild-type mouse PKR protein, subse-
measured by Western immunoblot analysis. Quantitation was with a
quently affecting the function of the PKR kinase. Our re- Bio-Rad GS 525 Phosphor Imager and is expressed as the percentage
sults reported herein demonstrate a physical interaction of the human PKR protein bound to the Sepharose affinity matrix. ND,
not determined.between the human protein kinase PKR and the mouse
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sess identical biological properties, at least when ex-
pressed in yeast. Differences in biological properties
have been observed between the mouse and the human
homologs of other IFN-regulated proteins, for example,
mouse Mx1 and human MxA, which display different anti-
viral activities (Pavlovic et al., 1993).
The precise role of RNA in PKR dimerization, and the
role of dimerization in PKR activation, is not yet well
resolved. Although most studies in which mutant human
PKR proteins were analyzed suggest that RNA is not
required for intraspecies dimerization (Patel et al., 1995;FIG. 4. Autophosphorylation of Sepharose-bound GST-MsPKR, immo-
bilized alone or in association with recombinant human PKR. Reaction Ortega et al., 1996, Wu and Kaufman, 1996), there re-
mixtures contained 0.1 mg/ml dsRNA. The region of the autoradiogram mains some question regarding the dependence of di-
corresponding to the 83-kDa 32P-labeled GST-MsPKR fusion protein is merization on RNA-binding activity (Cosentino et al.,shown. Lane 1, human U-cell PKR; lane 2, GST-MsPKR affinity matrix
1995). We observed, with both two-hybrid and GST-fusionalone; lane 3, GST-MsPKR affinity matrix in association with p220(WT)
chromatography assays, that interspecies PKR dimeriza-human PKR; lane 4, GST-MsPKR affinity matrix in association with
p220(K64E) mutant human PKR; lane 5, GST-MsPKR affinity matrix in tion between mouse and human PKR proteins was not
association with GST-HuPKR(K296R) fusion; lane 6, GST-HuPKR(K296R) dependent upon RNA binding, but rather was enhanced
fusion alone. when both PKR partners were capable of binding RNA.
This was the case when both the N-terminal region of
human PKR and the full-length human PKR protein werePKR physical interaction by GST-PKR fusion chromatog-
raphy was for the intraspecies human–human PKR ho- tested with mouse PKR (Tables 1–3). While both intra-
and interspecies dimerization of PKR can occur in anmodimer. By contrast, interspecies heterodimerization
between MsPKR and HuPKR from IFN-treated U-cells RNA-binding-independent manner, the presence of RNA
appears required for the conformational changes of PKRwas approximately twofold lower than the corresponding
human GST-PKR(K296R) fusion and wild-type PKR from that permit binding of ATP by the catalytic domain
(Bischoff and Samuel, 1985). Both genetic (Romano etIFN-treated human U-cells. The fact that the intraspecies
interactions of HuPKR are more efficient than those be- al., 1995) and biophysical (Carpick et al., 1997) analyses
suggest that the active form of PKR most likely is a dimertween interspecies PKR homologs may reflect the fact
that the 515-amino-acid mouse PKR homolog (Icely et together with a single RNA molecule, in which RNA bind-
ing mediates a conformational change within the cata-al., 1991; Baier et al., 1993; Tanaka and Samuel, 1994)
is smaller than the 551-amino-acid human PKR homolog lytic domain (Bischoff and Samuel, 1985; Carpick et al.,
1997). It is conceivable that the conformation of PKR that(Meurs et al., 1990; Thomis et al., 1992; Kuhen et al.,
1996). Exons 4 and 7 of the mouse protein, which are exists in the presence of bound RNA, a conformation
which permits ATP binding (Bischoff and Samuel, 1985),within the N-terminal region of PKR involved in the PKR –
PKR physical interactions, are among those exons that also facilitates PKR dimerization through protein–protein
contacts. However, the RNA-induced conformation ofdiffer the most in size between the cognate exons of the
human PKR homolog (Kuhen et al., 1996). PKR is not an obligate requirement for dimerization, at
least for the human homolog (Patel et al., 1995; OrtegaThe observation that wild-type mouse PKR expressed
in yeast did not exhibit a growth supression phenotype et al., 1996, Wu and Kaufman, 1996).
It has been reported that two different N-terminal frag-was unexpected. The HuPKR(WT) protein exhibits growth
suppression in yeast (Chong et al., 1992). Therefore, anal- ments of human PKR, either the terminal 184 or the 220
amino acids which contain the two copies of the dsRNA-yses of PKR–PKR interactions using the yeast two-hybrid
system have necessitated the use of catalytic deficient binding R-motif, form homodimer complexes in presence
of double-stranded RNA (Bevilacqua and Cech, 1996).mutant proteins such as HuPKR(K296R) (Ortega et al.,
1996). Catalytically inactive human PKR mutants reverse A 22–24-base-pair dsRNA is the minimal RNA length
required to form a dimer, a length of dsRNA that containsthe growth suppression phenotype of HuPKR(WT) in
yeast, and human PKR mutant proteins also cause malig- two turns of A-form dsRNA in which each one (11 base
pair) could possibly bind one PKR protein. The DG0 inter-nant transformation of mouse 3T3 cells (Koromilas et al.,
1992; Meurs et al., 1993). However, no evidence of tumor action free energy calculated for formation of the trun-
cated human PKR protein homodimer complexed withsuppressor activity of PKR was observed in studies of
knockout mice devoid of functional PKR (Yang et al., dsRNA suggests cooperation of binding of a second pro-
tein molecule to a preformed protein–dsRNA complex.1995). The lack of a growth suppressive effect caused
by MsPKR(WT) reported herein suggests the possibility This implies that once the first PKR protein binds to RNA,
it undergoes a conformational change that facilitates in-that the mouse and human PKR homologs do not pos-
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teraction with the second protein. In agreement with the dimerization with inactive human PKR suggests that
other mechanisms may be operative in addition to theresults of Bevilacqua and Cech (1996) obtained with the
human p184 and p220 PKR truncations, we find an RNA possible functional inhibition of endogenous PKR(WT).
Furthermore, the observation that yeast transformantsdependence of the interaction between wild-type mouse
PKR and either the 184- or the 220-amino-acid N-terminal which express both the wild-type mouse and the mutant
K296R human proteins grow normally suggests that thefragment of human PKR. Although heterodimerization oc-
curs with dsRNA-binding mutants p184(K64E) and phosphorylation levels in vivo are not perturbed in a phys-
iologically significant manner.p220(K64E), this interaction is about threefold less effi-
cient than the corresponding interaction between The p58 inhibitor of PKR and a mutant form of the eIF-
2a substrate of PKR which cannot be phosphorylated areMsPKR(WT) and either p184(WT) or p220(WT) truncated
HuPKR. Other investigators (Wu and Kaufman, 1997) also both oncogenic when overexpressed in mouse NIH3T3
cells (Barber et al., 1995a; Donze et al., 1995). Thesehave found an increase in PKR–PKR dimerization effi-
ciency after the addition of dsRNA. Our in vivo two-hybrid results suggest that one mechanistic explanation for the
oncogenic activity displayed by mutant forms of PKR (Kor-results obtained with the mouse and human PKR homo-
logs are comparable to those previously reported for hu- omilas et al., 1992; Meurs et al., 1993; Barber et al.,
1995b) in 3T3 cells indeed relates to a direct perturbationman PKR interaction with itself (Ortega et al., 1996); the
K64E mutation did not prevent PKR–PKR physical inter- of the homeostatic balance of translation. Human PKR
can form heterodimers with proteins such as the humanaction, either intra- or interspecies.
Although early studies suggested that autophosphory- p58 inhibitor of PKR (Barber et al., 1995a) and the human
TAR RNA-binding protein TRBP (Benkirane et al., 1997).lation of mouse (Berry et al., 1985) and human (Galabru
and Hovanessian, 1987) PKR proteins may occur in cis by Formation of these heterodimers inhibits the autoactiva-
tion of PKR in an RNA-binding-independent manner,an intramolecular mechanism, subsequent studies with
tagged mutant PKR and purified PKR(WT) enzymes firmly which may provide a primary explanation for the onco-
genic behavior of both p58 and TRBP when overex-established that autophosphorylation of human PKR can
occur in trans by an intermolecular mechanism (Thomis pressed in nude mice (Barber et al., 1995a; Benkirane et
al., 1997). However, no evidence of tumor suppressorand Samuel, 1993, 1995; Kostura and Mathews, 1989).
Of course, these data in support of intermolecular phos- activity of PKR was observed in studies of ‘‘knockout’’
mice devoid of functional PKR (Yang et al., 1995). Thisphorylation do not unequivocally preclude the coincident
occurrence of intramolecular phosphorylation events. suggests that the absence of functional PKR in itself may
not be sufficient to mediate malignant transformation, or,Genetic analysis of human PKR function in the yeast
Saccharomyces cerevisae revealed that two mutant PKR conversely, the presence of excess amounts of mutant
PKR may be required to mediate the progression ofproteins containing deletions of the first or the second
copies of the RNA-binding R-motif complemented each mouse NIH3T3 cells to the transformed state and subse-
quent tumor formation in nude mice. Thus, mechanismsother (Romano et al., 1995). The intermolecular homodi-
merization of human PKR in S. cerevisae occurs through other than, or in addition to, the functional inhibition of
endogenous PKR(WT) and subsequent direct perturba-physical interactions of the N-terminal region of PKR by
an RNA-independent mechanism (Ortega et al., 1996). tion of translation may be operative. One possible alter-
native mechanism for the transdominant responses as-Ample evidence has been presented that overex-
pression of transdominant mutant forms of human PKR sociated with the dysfunctional expression of PKR may
involve impaired signaling and altered transcriptional ac-deficient in catalytic activity (Koromilas et al., 1992; Meurs
et al., 1993) or RNA-binding activity (Barber et al., 1995b) tivation. For example, deficient cytokine signaling has
been observed in PKR0/0 mouse embryo fibroblasts de-can induce malignant transformation of mouse NIH3T3
cells. The mechanism responsible for this effect of dys- void of functional PKR (Kumar et al., 1997), and a physical
association between PKR and the STAT1 signal trans-functional PKR protein expression on cellular prolifera-
tion is not yet resolved. One intriguing possibility that ducer and activator of transcription has been reported
that requires the N-terminal RNA-binding region of PKR.has been advanced is that the mutant human PKR pro-
teins form heterodimers with the endogenous mouse This association decreases the STAT1 DNA-binding ac-
tivity (Wong et al., 1997). Our results firmly establish thatPKR protein in a manner that subsequently impairs func-
tion of the mouse PKR enzyme. Our results reported the human PKR protein can physically interact with the
mouse PKR homolog in vivo and in vitro. The interspeciesherein establish that the human PKR protein indeed can
form heterodimers with the mouse PKR protein. Surpris- association between human and mouse PKR proteins in
rodent cells in which a human mutant PKR is overex-ingly, however, the autoactivation of the mouse PKR pro-
tein was not impaired by dimerization with either the N- pressed could, therefore, perturb one or more of the nor-
mal functional associations of the endogenous mouseterminal or the full-length form of human PKR. The lack
of functional inhibition of the GST-MsPKR by the hetero- PKR(WT), for example, those related to either transla-
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binding protein TRBP and its regulatory interaction with RNA-depen-tional (Donze et al., 1995) or transcriptional responses
dent protein kinase PKR. EMBO J. 16, 611–624.(Kumar et al., 1997; Wong et al., 1997).
Berry, M. J., Knutson, G. S., Lasky, S. R., Munemitsu, S. M., and Samuel,In summary, biochemical and genetic analyses of the C. E. (1985). Purification and substrate specificities of the double-
transdominant mutant forms of PKR have revealed that stranded RNA-dependent protein kinase from untreated and inter-
at least two different mechanisms may be responsible for feron-treated mouse fibroblasts. J. Biol. Chem. 260, 11240–11247.
Bevilacqua, P. C., and Cech, T. R. (1996). Minor-groove recognition ofthe enhanced protein synthesis and induced malignant
double-stranded RNA by the double-stranded RNA-binding domaintransformation. One mechanism is independent of the
from the RNA-activated protein kinase PKR. Biochemistry 35, 9983–RNA-binding activity of PKR, as established by the ability
9994.
of RNA-binding-deficient mutants of PKR to mediate the Bischoff, J. R., and Samuel, C. E. (1985). Mechanism of interferon action:
dominant-negative phenotype (Barber et al., 1995b; Benk- The interferon-induced phosphoprotein P1 possesses a double-
stranded RNA-dependent ATP-binding site. J. Biol. Chem. 260, 8237–irane et al., 1997; Ortega et al., 1996). The other mecha-
8239.nism is likely dependent upon RNA-binding activity, as
Carpick, B. W., Graziano, V., Schneider, D., Maitra, R. K., Lee, X., andestablished by the ability of heterologous RNA-binding
Williams, B. R. G. (1997). Characterization of the solution complex
proteins to functionally substitute for RNA-binding suffi- between the interferon-induced, double-stranded RNA-activated pro-
cient catalytic mutants of PKR in enhancing translation tein kinase and HIV-I trans-activating region RNA. J. Biol. Chem. 272,
9510–9516.(Chong et al., 1992; Henry et al., 1994; Jacobs and Lang-
Chong, K. L., Feng, L., Schappert, K., Meurs, E., Donahue, T. F., Friesen,land, 1996; Wu and Kaufman, 1996) and the inability of
J. D., Hovanessian, A. G., and Williams, B. R. (1992). Human p68 ki-RNA-binding-deficient PKR mutants to affect STAT1 activ-
nase exhibits growth suppression in yeast and homology to theity (Wong et al., 1997). The demonstration that PKR–PKR translational regulator GCN2. EMBO J. 11, 1553–1562.
interspecies interactions occur in vitro and in vivo be- Clemens, M. J. (1996). Protein kinases that phosphorylate eIF-2 and
tween mouse and human PKR proteins in an RNA-bind- eIF-2B, and their role in eukaryotic cell translational control. In ‘‘Trans-
lational Control,’’ pp. 139–172. Cold Spring Harbor Laboratory Press,ing-independent manner is relevant to the former mecha-
Cold Spring Harbor, NY.nism. Surprisingly, however, when purified proteins were
Cosentino, G. P., Venkatesan, S., Serluca, F. C., Green, S. R., Mathews,examined, mouse PKR autophosphorylation was not im-
M. B., and Sonenberg, N. (1995). Double-stranded-RNA-dependent
paired by the physical association with human PKR mu- protein kinase and TAR RNA-binding protein form homo- and hetero-
tant proteins. It is now of importance to establish the dimers in vivo. Proc. Natl. Acad. Sci. USA 92, 9445–9449.
David, M. (1995). Transcription factors in interferon signaling. Pharmac.precise relationship between PKR dimerization and PKR
Ther. 65, 149–161.activation and to determine whether this process is
Donze, O., Jagus, R., Koromilas, A. E., Hershey, J. W. B., and Sonenberg,equivalent between interspecies PKR heterodimers and
N. (1995). Abrogation of translation initiation factor eIF-2 phosphory-intraspecies PKR homodimers. lation causes malignant transformaton of NIH3T3 cells. EMBO J. 14,
3828–2834.
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